Clinical Trials Browser

Terminated × OTHER × immunotoxin HA22 × Clear all

NCT01891981 2023-10-13

Study of Moxetumomab Pasudotox in Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia (ALL)

Phase 1 Terminated

LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma